Bradykinin (BA5201): Endothelium-Dependent Vasodilator in Research

What This Product Solves

Bradykinin (SKU BA5201) is a synthetic, well-characterized endothelium-dependent vasodilator peptide. It is specifically formulated for laboratory studies investigating vascular permeability modulation, smooth muscle contraction research, and inflammation signaling pathways. Researchers leverage this reagent to induce controlled vasodilation, model blood pressure regulation, and probe pain mechanism studies under reproducible, defined conditions. Its molecular weight (1060.21) and chemical formula (C₅₀H₇₃N₁₅O₁₁) are well-documented, supporting the design of quantitative and comparative protocols (product_spec).

Unlike crude extracts or uncharacterized peptides, BA5201 provides a consistent, quality-controlled source of Bradykinin for in vitro and ex vivo experimental systems. It is not suitable for diagnostic or therapeutic applications, nor for long-term solution storage, as outlined in the product documentation.

Protocol Parameters

• Reagent handling | Use promptly after reconstitution | All in vitro and ex vivo workflows | Bradykinin solutions are not stable for long-term storage and should be prepared fresh for each experiment | product_spec
• Storage conditions | -20°C, tightly sealed and desiccated | Stock powder storage | Maintains peptide stability and prevents degradation before use | product_spec
• Shipping temperature | Blue ice (2–8°C) | Shipment of small molecule and peptide reagents | Minimizes temperature-induced degradation during transit | product_spec
• Working concentration | Workflow-dependent, typically in nM–μM range | Cell-based assays, vascular tissue studies | Concentration selection guided by experimental design and literature precedents; not specified in product dossier, so users must validate empirically | workflow_recommendation

Workflow Setup and QC Checklist

To ensure the integrity and reproducibility of Bradykinin-dependent experiments, researchers should adhere to the following setup and quality control (QC) procedures:

1. Receiving and Storage: Upon delivery, immediately transfer the sealed vial to a -20°C freezer. Ensure desiccant is present and vial is protected from light. Verify shipment arrived on blue ice (product_spec).
2. Reconstitution: Prepare fresh solutions using sterile, ice-cold buffer (e.g., PBS or physiological saline) immediately before each experiment. Avoid repeated freeze-thaw cycles.
3. Aliquoting: If necessary, aliquot the stock powder under dry, cold conditions to minimize moisture and temperature exposure. Use low-binding tubes for peptide solutions.
4. Solution Verification: Confirm complete dissolution by gentle vortexing and brief centrifugation. If visible particulates persist, filter with a low-protein-binding membrane (0.22 μm).
5. Control Experiments: Include vehicle controls and, where possible, peptide concentration-response curves to validate assay sensitivity and specificity.
6. Documentation: Log lot number, reconstitution conditions, and timing of solution preparation to support traceability.

For additional workflow and troubleshooting guidance, see the relevant internal articles: Bradykinin: Vasodilator Peptide for Blood Pressure Regulation (offers detailed spectral troubleshooting and advanced comparative insights) and Bradykinin (BA5201): Data-Driven Solutions for Vascular and Cell Assays (scenario-driven protocol optimization and data reliability strategies).

Common Failure Modes and Fixes

• Peptide degradation: Inadequate cold chain or prolonged solution storage can lead to loss of activity. Always store the lyophilized product at -20°C and avoid keeping reconstituted solutions beyond the day of use (product_spec).
• Solubility issues: Bradykinin dissolves readily in aqueous buffer, but incomplete dissolution may occur if powder is exposed to moisture or not vortexed. Prepare solutions at room temperature, vortex gently, and filter as needed.
• Assay variability: Failure to standardize timing, concentrations, or controls may yield irreproducible results. Calibrate pipettes, prepare fresh solutions, and maintain consistent incubation conditions.
• Cross-contamination: Use dedicated tools and change gloves between handling different peptide vials or stocks.

Scope and Limitations

Bradykinin (BA5201) is validated for use in in vitro and ex vivo research applications requiring a defined endothelium-dependent vasodilator. The peptide’s documented role supports studies in vascular permeability modulation, smooth muscle contraction research, pain mechanism studies, and inflammation signaling pathway exploration. However, the product is not suitable for in vivo administration, diagnostic, or clinical applications. Solution stability is limited—long-term storage of reconstituted peptide is not supported. Concentration selection and workflow optimization remain the responsibility of the end user, as application-specific protocols are not specified in the product dossier.

Conclusion

Bradykinin (SKU BA5201) from APExBIO provides researchers with a rigorously characterized, reliable peptide standard for essential vascular and inflammation studies. When integrated into controlled workflows with appropriate QC, it enables reproducible interrogation of endothelium-dependent vasodilation and related signaling phenomena. For further application-specific strategies, refer to internal articles on advanced troubleshooting and assay optimization.